13F-HR/A: StoneX Amends 13F Filings, Corrects Under-Reported Holdings

StoneX Group Inc. filed an amended Form 13F-HR to correct under-reported securities, shares, and market values from Q4 2021 through Q1 2025 due to internal errors.

Summary

• StoneX Group Inc. filed an amended Form 13F-HR for the quarter ended June 30, 2023, to correct previous under-reporting of securities, shares, and market values.
• The under-reporting affected quarterly filings from Q4 2021 through Q1 2025.
• The errors impacted holdings reported by StoneX Advisors Inc., StoneX Financial Inc., and Trust Advisory Group, Ltd.
• Key causes identified include the inadvertent exclusion of three market-making accounts, an Excel formula error (using XLOOKUP instead of SUMIF), failure to implement an SEC rule change on dollar rounding, and an Excel scientific notation error affecting CUSIP identification.
• The amended report now includes 356 information table entries with a total market value of $177,440,735.

Sentiment

Score: 4

Explanation: The filing reveals significant, multi-year under-reporting errors due to systemic issues, which is negative. However, the company's internal review and subsequent amendment to correct these issues demonstrate a commitment to compliance and transparency, which is a positive step towards remediation. The errors themselves are concerning, but the act of correcting them mitigates some of the negative impact.

Positives

• StoneX Group Inc. conducted an internal review to identify and correct reporting discrepancies.
• The company is taking steps to rectify past under-reporting by filing an amendment.
• The amendment provides a more accurate representation of the firm's holdings, with a total market value of $177,440,735.

Negatives

• Quarterly filings from Q4 2021 through Q1 2025 under-reported the total number of securities, shares, and market values.
• Three market-making accounts were inadvertently excluded from filings between Q4 2021 and Q4 2024.
• An Excel formula error (using XLOOKUP instead of SUMIF) caused only the first instance of a CUSIP to be counted from Q1 2022 to Q4 2022.
• Failure to properly implement SEC Rule 87 FR 38943 regarding rounding dollar values to the nearest dollar occurred from Q4 2022 to Q1 2025.
• CUSIPs containing 'E' were inadvertently converted into scientific notation in Excel, leading to misidentification of reportable securities between Q4 2021 and Q1 2025.

Risks

• Operational risks related to data management and reporting accuracy, as evidenced by multiple systemic errors (Excel formula errors, scientific notation conversion issues).
• Compliance risks due to failure to properly implement SEC rule changes (e.g., rounding requirements).
• Reputational risk associated with under-reporting and the need for multiple amendments to correct historical data.
• Potential for regulatory scrutiny or penalties related to past non-compliance with reporting requirements.

Future Outlook

NA

Management Comments

• During an internal review of StoneX Group Inc.'s Section 13(f) reporting practices we discovered the quarterly filings from Q4 2021 through Q1 2025 under-reported the total number of securities, shares and market values.
• The errors involved all Other Reporting Managers: StoneX Advisors Inc., StoneX Financial Inc., and Trust Advisory Group, Ltd.

Industry Context

This amended filing highlights the critical importance of robust internal controls and accurate data management for institutional investment managers in the highly regulated financial industry. Such errors, even if unintentional, underscore the ongoing challenges firms face in maintaining compliance with complex SEC reporting requirements, particularly concerning large and diverse portfolios. It serves as a reminder for all market participants to regularly review and update their reporting systems and processes to avoid similar discrepancies.

Comparison to Industry Standards

• The identified errors in reporting, such as Excel formula mistakes and failure to implement regulatory changes, fall below the industry standard for data accuracy and compliance expected of institutional investment managers.
• Leading financial institutions typically employ sophisticated data validation and compliance systems to prevent the types of systemic errors (e.g., CUSIP misidentification due to scientific notation, incorrect rounding) that StoneX Group Inc. experienced.
• While the internal review and subsequent amendment demonstrate a commitment to correction, the multi-year period of under-reporting (Q4 2021 through Q1 2025) suggests a lapse in internal audit or quality control processes compared to best practices in the financial sector.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides a more accurate view of the company's reported holdings, which can improve transparency and trust. However, the revelation of past under-reporting might raise concerns about the reliability of historical data.
• Regulatory Authorities: Demonstrates the company's effort to comply with SEC regulations by correcting past errors, potentially mitigating further regulatory action, but also highlighting areas where oversight may have been insufficient.
• Investment Professionals: Offers corrected data for analysis, allowing for more informed investment decisions regarding StoneX's reported portfolio.

Next Steps

• StoneX Group Inc. is expected to ensure that the identified causes of under-reporting (missing accounts, Excel errors, rule implementation failures) are fully rectified to prevent future occurrences.
• Ongoing internal reviews and enhancements to reporting practices are implied to maintain compliance with SEC regulations.

Key Dates

Recommendation

The filing reveals significant, multi-year under-reporting issues stemming from operational and compliance failures. While the company's internal review and subsequent amendment to correct these errors are positive steps towards transparency and remediation, the underlying issues raise concerns about the robustness of their internal controls and data management. Investors should 'hold' to observe if the company implements comprehensive and effective measures to prevent recurrence and to assess any potential regulatory repercussions. A 'buy' would be premature given the past deficiencies, and a 'sell' might be an overreaction if the corrections are effectively implemented and no further issues arise.

Keywords

StoneX Group Inc., SEC Form 13F-HR/A, Investment Holdings, Under-reporting, Compliance Errors, Financial Reporting, Market Making Accounts, SEC Rule 87 FR 38943, Data Accuracy, Institutional Investment Manager